Stephanie Lee, MD, MPH, and Richard A. Larson, MD, are featured.

graphic

Stephanie Lee, MD, MPH, began a 1-year term as president of the American Society of Hematology (ASH)this month at the organization's 2019 Annual Meeting in Orlando, FL. She is a professor of oncology and medicine at the University of Washington and a member of the Fred Hutchinson Cancer Research Center in Seattle. Lee is also the research director of the Fred Hutchinson Long-Term Follow-Up Program, which tracks patients after bone-marrow or stem-cell transplants. Her research focuses on developing better ways to prevent, diagnose, and treat graft-versus-host disease.

graphic

Also at the ASH meeting, Richard A. Larson, MD, professor of medicine and director of the Hematologic Malignancies Clinical Research Program at the University of Chicago in Illinois, won the Henry Stratton Medal for Clinical/Translational Research. His work has centered on understanding the genetic basis of leukemia and developing new therapies. As chair of what is now the Alliance for Clinical Trials in Oncology, Larson oversaw numerous leukemia trials. Larson has also served on the editorial boards of several journals.

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.